Skip to main content
OpenTrials
Completed

NCT Number: NCT04847817

Important Data on COVID-19 Profile in Africa

The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19) infection to better define the period of infectiousness and transmissibility and to establish biobanks of COVID-19 blood and mucosal samples.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus Infection Africa COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Severe Acute Respiratory Syndrome Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre de Recherches Médicales de Lammbaréné, Lambaréné, Moyen-Ogooué Province, Gabon

Loading trial locations.

About this study

In this study ,the participants will be enrolled sequentially in the COVID-19 care referral centers. The infected hospitalized patient will be identified by the physicians in hospital. After the patient has given his/her informed consent the permission will be sought from him to approach his household contacts. The household contacts will be screened, and included in the study.

Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all ages and gender (40% minimum of female), will be enrolled upon receipt of written informed consent.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Molecular (PCR) confirmed COVID-19 patients hospitalized in referral centers,
  • Household contacts of hospitalized COVID-19 patient,
  • Provided signed informed consent.

Exclusion criteria

  • Pregnancy

Treatment and study plan

Primary outcomes

  1. clinical and biological parameters of COVID-19

    Time frame: 14 days

    Infection and disease progression - Pattern of virus transmission

  2. SARS-CoV-2 transmissibility

    Time frame: 14 days

    proportion of household contact who will become positive for SARS-COV2 using PCR

Sponsors and collaborators

Lead sponsor

Centre de Recherche Médicale de Lambaréné

Other

Collaborators

  • Armauer Hansen Research Institute, Ethiopia
  • European and Developing Countries Clinical Trials Partnership (EDCTP)
  • Institut de recherche en santé de surveillance épidémiologique et de formation
  • Leiden University Medical Center
  • Universität Tübingen
  • Université des Sciences de la Santé

Registry information

Acronym: AIDCO

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Apr 19, 2021
Registry last updated
Jul 19, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.